In preclinical retinoblastoma models, the combined subconjunctival injection of Nutlin-3 with a topoisomerase inhibitor, topotecan, induced a p53 response that is similar to that induced by 5 Gy of ionizing radiation. This evidence concerns the gene TP53 and retinoblastoma.